Mann Jeffrey Z purchased $100K of EMBC
Mann Jeffrey Z (Pres, Pharm Svc&Prod Mgmt, CLO) purchased 20,000 shares of Embecta Corp. (EMBC) at $4.99 on 2026-08-12.
How this was made
The 30-second read
Why it matters
The newest fact is the officer’s open-market purchase of 20,000 shares at $4.9900 on 2026-08-12, filed on 2026-08-13.
Market read
Traders may note the insider buy as a small sentiment input, but there is no accompanying fundamental catalyst in the text.
What to watch
The article does not state whether the purchase was part of a broader pattern, nor does it provide context on prior holdings changes or company fundamentals.
Background
This is an SEC Form 4 insider transaction disclosure for Embecta Corp. (EMBC).
Ticker impact
Embecta insider Jeffrey Z Mann bought 20,000 shares on 2026-08-12 at $4.9900, totaling $99,800, per Form 4.
Low likelihood of a sustained move; any reaction is likely limited and short-lived.
The filing is primary-source and time-stamped, but it is an insider buy without a 10b5-1 plan and without accompanying guidance, contracts, or earnings data.
Market effects
No direct sector read-through; this is an issuer-specific insider transaction.
None indicated.
None indicated.
Counterpoint
Insider purchases can be driven by diversification, liquidity needs, or routine compensation-related activity, so the signal may be weaker than it appears.
Key entities
- issuerEmbecta Corp.
Subject of the Form 4 insider transaction disclosure.
- insiderMann Jeffrey Z
President, Pharm Svc and Product Management, CLO, reported an open-market purchase.
